CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)	Total	Common Stock	Additional Paid-in Capital	[1]	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020		10,231,454
Beginning balance at Dec. 31, 2020	$ 32,142,113	$ 1,023	$ 164,202,357		$ (132,061,267)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)		1,850,861
Issuance of common stock	37,218,588	$ 185	37,218,403
Vesting of RSUs (in shares)		10,185
Vesting of RSUs	0	$ 1	(1)
Share-based compensation	2,413,000		2,413,000
Stock issuance costs	(2,901,123)		(2,901,123)
Exercise of warrants (in shares)		777,344
Exercise of warrants	9,163,174	$ 78	9,163,096
Exercise of stock options (in shares)		41,932
Exercise of stock options	346,961	$ 4	346,957
Net loss	$ (36,779,400)				(36,779,400)
Ending balance (in shares) at Dec. 31, 2021	12,911,776	12,911,776
Ending balance at Dec. 31, 2021	$ 41,603,313	$ 1,291	210,442,689		(168,840,667)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)		68,861
Issuance of common stock	500,000	$ 7	499,993
Share-based compensation	3,938,000		3,938,000
Settlement of convertible debt and accrued interest (in shares)		55,719
Settlement of convertible debt and accrued interest	125,645	$ 6	125,639
Net loss	$ (43,766,415)				(43,766,415)
Ending balance (in shares) at Dec. 31, 2022	13,036,356	13,036,356
Ending balance at Dec. 31, 2022	$ 2,400,543	$ 1,304	$ 215,006,321		$ (212,607,082)

[1]    1Amounts have been retroactively restated to reflect the 1-for-20 reverse stock split effected on October 17, 2022 (see Note 1)